| Literature DB >> 30091317 |
Jin Young Ahn1, Je Eun Song2, Hea Won Ann1, Yongduk Jeon1, Mi Young Ahn1, In Young Jung1, Moo Hyun Kim1, Wooyoung Jeong1, Su Jin Jeong1,3, Nam Su Ku1,3, June Myung Kim1,3, Sungwon Na4, Sung Rae Cho5, Jun Yong Choi1,6.
Abstract
PURPOSE: Severe sepsis is associated with functional disability among patients surviving an acute phase of infection. Efforts to improve functional impairment are important. We assessed the effects of early exercise rehabilitation on functional outcomes in patients with severe sepsis.Entities:
Keywords: Sepsis; exercise rehabilitation; functional outcome; functional recovery; septic shock
Mesh:
Year: 2018 PMID: 30091317 PMCID: PMC6082977 DOI: 10.3349/ymj.2018.59.7.843
Source DB: PubMed Journal: Yonsei Med J ISSN: 0513-5796 Impact factor: 2.759
Fig. 1Flow chart of the study participation.
Baseline Characteristics of Study Participants
| Factors | Intervention group (n=21) | Control group (n=19) | |
|---|---|---|---|
| Demographic factors | |||
| Male | 8 (38.1) | 9 (47.4) | 0.342 |
| Age (yr) | 77.0 [69.5–78.5] | 70.0 [66.0–77.0) | 0.797 |
| BMI (kg/m2) | 22.1 [19.3–24.6] | 23.4 [20.2–26.6] | 0.303 |
| Length of hospital stay (day) | 12 [9.0–29.5] | 11 [8.0–16.0] | 0.221 |
| Total intervention day (day) | 8 [6.0–16.5] | - | |
| Comorbidities | |||
| HTN | 12 (57.1) | 13 (68.4) | 0.528 |
| DM | 7 (33.3) | 8 (42.1) | 0.319 |
| Cardiovascular disease | 3 (14.3) | 3 (15.8) | 1.000 |
| CHF | 2 (9.5) | 1 (5.3) | 1.000 |
| CVA | 3 (14.3) | 2 (10.5) | 1.000 |
| Chronic lung disease | 2 (9.5) | 0 (0) | 0.488 |
| Chronic renal disease | 3 (14.3) | 7 (36.8) | 0.104 |
| Chronic liver disease | 1 (4.8) | 5 (26.3) | 0.085 |
| Metastatic malignancy | 2 (9.5) | 6 (31.6) | 0.120 |
| Organ transplant recipient | 1 (4.8) | 0 (0) | 1.000 |
| Rheumatologic disease | 3 (14.3) | 3 (15.8) | 1.000 |
| Charlson comorbidity score | 4.0 [3.0–6.0] | 6.0 [5.0–8.0] | 0.007 |
| Clinical characteristics on admission | |||
| Shock | 21 (100) | 18 (94.7) | 0.475 |
| Use of inotropics | 21 (100) | 17 (89.5) | 0.219 |
| Acute kidney injury | 13 (61.9) | 12 (63.2) | 0.936 |
| RRT | 3 (14.3) | 1 (5.3) | 0.607 |
| Acute lung injury | 4 (19.0) | 0 (0) | 0.108 |
| Ventilator care | 4 (19.0) | 0 (0) | 0.108 |
| ICU care | 4 (19.0) | 2 (10.5) | 0.664 |
| CRP (mg/dL) | 177.0 [96.0–230.5] | 117.0 [56.0–234.0] | 0.255 |
| Procalcitonin | 23.6 [7.1–111.5] | 21.4 [2.8–44.4] | 0.642 |
| SOFA score | 6.0 [4.5–8.5] | 6.0 [5.0–10.0] | 0.990 |
| APACHE II score | 16.0 [9.0–20.5] | 17.0 [14.0–20.0] | 0.642 |
| Primary source of infection | 0.625 | ||
| Pneumonia | 4 (19.0) | 2 (10.5) | |
| Urinary tract infection | 9 (42.9) | 9 (47.4) | |
| Intra-abdominal infection | 5 (23.8) | 4 (21.1) | |
| Gastroenteritis | 3 (14.3) | 1 (5.3) | |
| Others | 0 (0) | 3 (15.8) | |
| Outcome | |||
| Overall 1 month mortality | 0 (0) | 0 (0) | - |
| Overall 6 month mortality | 3 (14.3) | 4 (21.1) | 0.574 |
BMI, body mass index; HTN, hypertension; DM, diabetes mellitus; CHF, congestive heart failure; CVA, cerebrovascular accident; RRT, renal replacement therapy; ICU, intensive care unit; CRP, C-reactive protein; SOFA score, the Sequential Organ Failure Assessment score; APACHE II score, Acute Physiology and Chronic Health Evaluation II score.
Data are presented as number (%) or median [interquartile range].
Functional Outcomes at Time of Assessment according to Study Group
| Outcome measure | Intervention group (n=21) | Control group (n=19) | |
|---|---|---|---|
| MBI score, mean (±SD) | |||
| Before admission | 95.43 (±8.54) | 97.05 (±5.28) | 0.479 |
| At study enrollment | 41.43 (±34.76) | 48.42 (±27.09) | 0.486 |
| At hospital discharge | 89.45 (±12.67) | 80.82 (±19.96) | 0.120 |
| At 6 month follow-up | 91.33 (±22.02) | 93.86 (±11.92) | 0.702 |
| FIM score, mean (±SD) | |||
| Before admission | 121.48 (±8.64) | 122.58 (±8.64) | 0.644 |
| At study enrollment | 64.38 (±33.30) | 72.89 (±21.31) | 0.347 |
| At hospital discharge | 114.30 (±12.94) | 104.29 (±23.35) | 0.129 |
| At 6 month follow-up | 116.88 (±24.93) | 119.21 (±14.22) | 0.759 |
| IADL score, mean (±SD) | |||
| Before admission | 21.43 (±3.65) | 22.68 (±2.38) | 0.203 |
| At study enrollment | 12.10 (±4.41) | 13.37 (±3.73) | 0.316 |
| At hospital discharge | 19.50 (±5.23) | 18.41 (±5.23) | 0.532 |
| At 6 month follow-up | 21.67 (±4.03) | 21.93 (±3.69) | 0.851 |
MBI, Modified Barthel Index; FIM, Functional Independence Measure; IADL, Instrumental Activity of Daily Living; SD, standard deviation.
Fig. 2Distribution of MBI grades over time according to study group. Numbers within bars represent the number of participants. MBI, Modified Barthel Index.
Fig. 3Change in functional outcome (MBI, FIM, and IADL) scores during the study period in the intervention and control groups. (A) Changes in mean MBI score. (B) Changes in mean FIM score. (C) Changes in mean IADL score. Means were calculated and compared between groups at each time point using a linear mixed model. Error bars represent standard error. MBI, Modified Barthel Index; FIM, Functional Independence Measure; IADL, Instrumental Activity of Daily Living.
Baseline Characteristics and Change in Functional Outcome Scores during Hospital Stay in a Subgroup with APACH II Scores ≥10
| Factors | Intervention group (n=16) | Control group (n=18) | |
|---|---|---|---|
| Patient characteristics | |||
| Male | 7 (43.8) | 9 (50) | 0.716 |
| Age (yr) | 77 [68–78] | 70.5 [65.75–77.75] | 0.097 |
| BMI (kg/m2) | 22.4 [20.3–25.1] | 23.6 [20.3–26.7] | 0.523 |
| Length of hospital stay (day) | 14 [9.0–30.3] | 11 [8–18.3] | 0.200 |
| Total intervention day (day) | 9 [6.3–18.3] | - | |
| Charlson comorbidity score | 4.5 [3.0–6.5] | 6.5 [5.0–8.0] | 0.009 |
| Shock | 16 (100) | 17 (94.4) | 0.346 |
| ICU care | 3 (18.8) | 2 (11.1) | 0.536 |
| SOFA score | 7.5 [14.3–21.8] | 6.0 [5.0–9.3] | 0.522 |
| APACHE II score | 19.0 [14.3–21.8] | 17.0 [14.8–20.3] | 0.663 |
| Baseline MBI | 36.44 (±34.37) | 50.5 (±26.26) | 0.187 |
| Baseline FIM | 62.88 (±33.65) | 73.94 (±21.42) | 0.256 |
| Baseline IADL | 12.13 (±4.66) | 13.50 (±3.79) | 0.350 |
| Mean change of outcome (from baseline to hospital discharge) | |||
| MBI | 55.13 (±36.45) | 31.75 (±25.98) | 0.048 |
| FIM | 52.40 (±33.29) | 31.25 (±20.33) | 0.045 |
| IADL | 7.60 (±4.79) | 5.06 (±3.79) | 0.112 |
BMI, body mass index; ICU, intensive care unit; SOFA score, the Sequential Organ Failure Assessment score; APACHE II score, Acute Physiology and Chronic Health Evaluation II score; MBI, Modified Barthel Index; FIM, Functional Independence Measure; IADL, Instrumental Activity of Daily Living; SD, standard deviation. Data are presented as number (%), median [interquartile range], or mean (±standard deviation).